We further hypothesized that interruption of this signaling axis with EGFR or NF-κB inhibitors of silencing of ProT or HOTAIR would ameliorate cisplatin-induced bladder cancer cachexia. This evidence concerns the gene SLC6A7 and urinary bladder carcinoma.